Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sopharma unveils plans for new pharma plant in Bulgaria
Sopharma will break ground for its new plant on 9 December 2010 and will be investing $47m, according to novinite.com. The CEO of Sopharma Ognyan Donev, together with
Sopharma will break ground for its new plant on 9 December 2010 and will be investing $47m, according to novinite.com. The CEO of Sopharma Ognyan Donev, together with
AiCuris said that the trial has been completed two months earlier than planned. Indeed, in the later stages of the trial, enrollment had to be restricted as the
The new analysis ‘Strategic Analysis of Russian Pharmaceutical Market’ found that the market will reach $37.15bn in 2016. The Russian government initiative 2020 Pharmaceutical Development Programme (Pharma 2020)
The Pennsylvania facility has been engaged primarily in contract manufacturing of molded plastic components and assemblies for consumer-product applications. The Cornwall facility produces molded elastomeric components for disposable
Egrifta is a synthetic analogue of the human growth hormone releasing factor (GRF) shown to reduce visceral fat in HIV-infected patients with excess abdominal fat associated with lipodystrophy.
In the study, the patients receive chemotherapy concurrent with either Herceptin intravenous (IV) or Herceptin SC every three weeks for the first 8 cycles. Roche said that Herceptin
The company has promoted Michael Shepard as the chief scientific officer after having joined the company as vice president of discovery research. Halozyme president and CEO Gregory Frost
Sunstar has already launched a pro-biotic lozenge called PerioBalance and is already Sinclair’s partner for Aloclair, the patented mouth ulcer gel and mouth rinse, marketed in the Americas
The application for the 30mg strength is filed as an amendment to the ANDA that Intellipharmaceutics had previously filed for the 5, 10, 15 and 20mg strengths of
Preliminary assessment of the immunological effects of CYT107 in 8 evaluable patients showed a median increase in CD4 T cells exhibiting a naïve or central memory phenotype of